drugset / Trial / NCT01299285
Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects
NaSingle-groupOpen-labelOther
Summary
This is a single dose study of radiolabeled \[14C\]-LY3009104 in healthy male volunteers to study the absorption, distribution, metabolism, and elimination of LY3009104. This study requires minimum of 7 days and maximum of 22 days stay. This study is for research purposes only and is not intended to treat any medical condition.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | 10 mg | Oral |
Indications
No indication recorded.